Phone Check-Ins could prevent falls during chemo

NCT ID NCT05330104

Completed Knowledge-focused Sponsor: Allina Health System Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether brief smartphone surveys can help detect early signs of fall risk in people receiving chemotherapy that can cause nerve damage. Twelve cancer patients used a mobile app to report symptoms like numbness or tingling in their legs. The goal was to see if patients would stick with the surveys and find them useful, not to treat the nerve damage itself.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mobile Ecological Momentary Assessment (mEMA) surveys
What this could lead to: If successful, this approach could help identify patients at risk of falling early, allowing them to get rehab and continue life-saving chemotherapy.
What could go wrong: This is a very small feasibility study with only 12 participants. It does not test a treatment, only a monitoring method, so it may not lead to direct patient benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chemotherapy-induced neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

Contacts and locations

Locations

Abbott Northwestern Hospital

Minneapolis, Minnesota, 55447, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.